Fenofibrate Capsules, USP 200 mg, Rx only, 100 Capsules, Manufactured by: Ajanta Pharma Limited, India, Marketed by: Ajanta Pharma USA Inc. Bridgewater, NJ 08807, NDC 27241-120-04.
Published July 1, 2026 · Recall initiated: May 28, 2026
Summary
FDA records drug Class II recall D-0611-2026, published July 1, 2026 and initiated May 28, 2026. Recalling firm: Ajanta Pharma USA Inc; Status: Ongoing; Reported quantity: 3648 bottles; Lot: Lot # PA02216; Exp. 12/2029. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
CGMP Deviations
What to do
Voluntary: Firm initiated
Get an email if FENOFIBRATE has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- FENOFIBRATE
- Manufacturer
- Ajanta Pharma USA Inc
- Distributor
- U.S. Nationwide
- UPC
- 0327241119040
- Lot
- Lot # PA02216; Exp. 12/2029
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDACarton Label: MAJOR, Methylergonovine Maleate Tablets, USP, 0.2 mg, 20 TABLETS (2 x 10), Rx only, Packaged andJuly 1, 2026
- FDACorlanor (ivabradine) tablets, 5 mg, packaged in a) 14 tablets bottles (NDC 55513-800-99), and b) 60 tabletJuly 1, 2026
- FDABrand Name: HeartMate Product Name: HM 11V Li-ion Backup Battery, ABT Model/Catalog Number: 106128 SoftwareJune 24, 2026
- FDAFenofibrate Capsules 67 mg, USP, 100-count bottle, Rx Only, Manufactured by: Glenmark Pharmaceuticals Limited,April 16, 2025
- FDAFENOFIBRATE CAPSULES, UPS 67MG 100 CAPSULES NDC/UPC 27241-118-04; RX; CAPSULESJune 2, 2021
- FDAFenofibrate Tablets, USP 145 mg, 90-count bottles, Rx only, Manufactured for: Camber Pharmaceuticals, Inc.October 3, 2018
Questions about this recall
Was Fenofibrate Capsules, USP 200 mg, Rx only, 100 Capsules, Manufactured by: Ajanta Pharma Limited, India, Marketed by: Ajanta Pharma USA Inc. Bridgewater, NJ 08807, NDC 27241-120-04. recalled?
Yes. FDA published recall D-0611-2026 on July 1, 2026. Reported hazard: CGMP Deviations
What should I do if I have this product?
Voluntary: Firm initiated
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: FENOFIBRATE. UPC: 0327241119040.